Composition of sodium ozagrel and polyethylene glycol and preparation method thereof

A technology of ozagrel sodium and polyethylene glycol, which is applied in the field of medicine, can solve problems such as poor stability, limited dosage, and easy precipitation, and achieve improved stability in vivo, improved effectiveness, and good brain targeting Effect

Inactive Publication Date: 2010-07-21
BEIJING SIHUAN PHARMA +1
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The pH value of ozagrel sodium is 8.0-9.5. It has poor stability under neutral pH conditions, is easy to precipitate, and produces isomers, which is not conducive to its long-term storage. In addition, the efficacy of its isomers is not good, thus affecting The efficacy of sodium ozagrel in the body
[0004] At the same time, as a drug acting on the brain, the permeability of the blood-brain barrier is an important factor for drug activity. The brain targeting of the existing ozagrel sodium is not ideal, and the amount of drug reaching the brain is limited, which affects its efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition of sodium ozagrel and polyethylene glycol and preparation method thereof
  • Composition of sodium ozagrel and polyethylene glycol and preparation method thereof
  • Composition of sodium ozagrel and polyethylene glycol and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment O

[0060] The preparation of embodiment OJ freeze-dried powder preparation

[0061] 1. Prescription

[0062] Prescription 1:

[0063] Sodium Ozagrel 20g

[0064] PEG-40000.008g

[0065] Mannitol 4g

[0066] Add water for injection to 1000mL

[0067]

[0068] A total of 1000 bottles were made

[0069] Prescription 2:

[0070] Sodium Ozagrel 20g

[0071] PEG-4000 0.02g

[0072] Mannitol 4g

[0073] Add water for injection to 1000mL

[0074]

[0075] A total of 1000 bottles were made

[0076] Prescription 3:

[0077] Sodium Ozagrel 40g

[0078] PEG-40000.08g

[0079] Mannitol 8g

[0080] Add water for injection to 1000mL

[0081]

[0082] A total of 1000 bottles were made

[0083] Prescription 4:

[0084] Sodium Ozagrel 40g

[0085] PEG-40000.4g

[0086] Mannitol 8g

[0087] Add water for injection to 1000mL

[0088] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a composition of sodium ozagrel and polyethylene glycol and a preparation method thereof, belonging to the medical technical field. The weight ratio of sodium ozagrel to polyethylene glycol in the pharmaceutical composition is 1:0.002-0.1. Injections can be prepared by using the pharmaceutical composition and auxiliary material which is acceptable in pharmacy and the auxiliary material is selected from one or more of lactose, mannitol, sorbitol, dextran, citric acid-sodium citrate and sodium bicarbonate-sodium carbonate. The pharmaceutical composition is used to cure dyskinesia associated with acute thrombotic infarction and cerebral infarction.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a composition of sodium ozagrel and polyethylene glycol and a preparation method thereof, and the preparation of the composition for the treatment of acute thrombotic cerebral infarction and movement disorders accompanied by cerebral infarction Uses in medicine. Background technique [0002] Ozagrel Sodium (Ozagrel Sodium) is a highly effective and selective inhibitor of thromboxane synthase, through the inhibition of thromboxane A 2 (TXA 2 ) production and promote prostacyclin (PGI 2 ) to improve the imbalance between the two, and has anti-platelet aggregation and vasodilator effects. It can inhibit cerebral vasospasm, increase cerebral blood flow, improve microcirculation disorder and abnormal energy metabolism in the brain, thereby improving cerebral ischemic symptoms in patients with subarachnoid hemorrhage and ataxia in patients with cerebral thrombosis (acut...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4174A61K47/34A61K9/19A61P7/02A61P9/10A61P25/14A61K47/10
Inventor 车冯升郭维城贾中新霍彩霞孟宪慧
Owner BEIJING SIHUAN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap